The modern discourse surrounding neuropharmacology, treatment-resistant psychiatric conditions, and alternative therapeutic interventions is experiencing a fundamental paradigm shift. Obsessive-Compulsive Disorder (OCD) has long challenged conventional psychiatry, frequently resisting standard pharmacological agents such as selective serotonin reuptake inhibitors (SSRIs) and rigorous cognitive behavioral modalities like exposure and response prevention (ERP). For individuals navigating severe, debilitating neurological […]